DR MB GHAFOOR & PARTNERS — All Prescriptions & Medications — Page 2
Practice Code: P86619 | ROCHDALE, OL11 1DN
Showing results 51-100 of 502
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tirzepatide | 496 | 532 | £52.2K | +155.4% ▲ |
| 495 | 56.7K | £1.6K | +79.0% ▲ | |
| Macrogol 3350 | 489 | 21.4K | £3.6K | -47.9% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 473 | 29.8K | £1.3K | +163.2% ▲ |
| Zopiclone | 471 | 4,859 | £235 | -14.9% ▼ |
| Lactulose | 466 | 218.2K | £2.0K | +41.5% ▲ |
| Lisinopril | 465 | 18.7K | £2.4K | -57.6% ▼ |
| Finasteride | 457 | 14.9K | £521 | -30.2% ▼ |
| Candesartan cilexetil | 456 | 17.1K | £819 | -61.6% ▼ |
| Furosemide | 454 | 34.8K | £2.3K | -69.4% ▼ |
| Ranolazine | 441 | 29.5K | £5.3K | +159.5% ▲ |
| Indapamide | 410 | 13.9K | £578 | -52.5% ▼ |
| Tramadol hydrochloride | 401 | 18.5K | £834 | -44.1% ▼ |
| Glimepiride | 396 | 19.8K | £606 | +329.2% ▲ |
| Flucloxacillin sodium | 393 | 18.1K | £837 | -12.6% ▼ |
| Fluoxetine hydrochloride | 389 | 14.0K | £642 | -61.6% ▼ |
| Alendronic acid | 372 | 1,744 | £391 | -50.4% ▼ |
| Perindopril erbumine | 368 | 13.1K | £1.1K | -30.7% ▼ |
| Alginic acid compound preparations | 359 | 163.6K | £2.6K | -38.7% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 344 | 39.8K | £1.5K | +12.3% ▲ |
| Betamethasone esters | 340 | 17.9K | £2.7K | +463.6% ▲ |
| Influenza | 329 | 329 | £3.9K | -79.0% ▼ |
| Linagliptin | 323 | 10.1K | £11.4K | -21.1% ▼ |
| Dexamethasone | 321 | 1,750 | £1.1K | +86.7% ▲ |
| Spironolactone | 320 | 8,976 | £969 | -40.6% ▼ |
| Promethazine hydrochloride | 308 | 18.5K | £1.5K | -13.8% ▼ |
| Doxycycline hyclate | 304 | 5,983 | £570 | -40.7% ▼ |
| Loratadine | 303 | 29.6K | £760 | +45.0% ▲ |
| Olanzapine | 303 | 8,099 | £1.1K | -18.2% ▼ |
| Dulaglutide | 300 | 1,281 | £23.5K | +161.8% ▲ |
| Simvastatin | 298 | 10.2K | £273 | -82.5% ▼ |
| Betamethasone valerate | 289 | 24.5K | £1.5K | -24.9% ▼ |
| 289 | 558 | £19.7K | -47.0% ▼ | |
| Biphasic insulin aspart | 286 | 2,696 | £16.1K | +181.7% ▲ |
| Alogliptin | 286 | 9,082 | £8.2K | +12.8% ▲ |
| Semaglutide | 285 | 1,059 | £26.7K | +18.4% ▲ |
| Budesonide | 283 | 305 | £7.7K | -47.8% ▼ |
| Insulin aspart | 277 | 1,607 | £10.1K | -27.3% ▼ |
| Sitagliptin | 277 | 7,308 | £444 | -29.0% ▼ |
| 276 | 333 | £433 | +25.3% ▲ | |
| 274 | 167.4K | £1.4K | +200.5% ▲ | |
| Esomeprazole | 270 | 10.0K | £737 | -33.3% ▼ |
| Isophane insulin | 268 | 1,650 | £7.2K | +153.8% ▲ |
| Insulin glargine | 267 | 1,423 | £10.3K | -6.0% ▼ |
| Duloxetine hydrochloride | 261 | 8,715 | £640 | -58.9% ▼ |
| Tadalafil | 256 | 1,960 | £397 | +50.6% ▲ |
| Citalopram hydrobromide | 253 | 7,812 | £185 | -85.8% ▼ |
| Dapagliflozin/metformin | 250 | 17.1K | £10.6K | +469.2% ▲ |
| Solifenacin | 246 | 7,934 | £295 | -48.4% ▼ |
| Piroxicam | 245 | 15.3K | £400 | +326.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.